Long-term opioid therapy in neuropathy: benefit or harm?
Crossref DOI link: https://doi.org/10.1038/nrneurol.2017.101
Published Online: 2017-07-21
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sommer, Claudia
Text and Data Mining valid from 2017-07-21
Article History
First Online: 21 July 2017
Competing interests
: The author has served as a consultant, given educational talks and has been involved in clinical trials for Air Liquide, Astellas, GrĂ¼nenthal and Pfizer.